145 related articles for article (PubMed ID: 33547013)
1. Does Multifocal Papillary Thyroid Microcarcinoma With a Total Tumor Diameter >1 cm Indicate Poor Biological Behavior? The Evidence is Insufficient.
Zhou B; Wei L; Qin J
Endocr Pract; 2021 Feb; 27(2):131-136. PubMed ID: 33547013
[TBL] [Abstract][Full Text] [Related]
2. SHOULD MULTIFOCAL PAPILLARY THYROID CARCINOMAS CLASSIFIED AS T1A WITH A TUMOR DIAMETER SUM OF 1 TO 2 CENTIMETERS BE RECLASSIFIED AS T1B?
Tam AA; Ozdemir D; Ogmen BE; Fakı S; Dumlu EG; Yazgan AK; Ersoy R; Cakır B
Endocr Pract; 2017 May; 23(5):526-535. PubMed ID: 28156153
[TBL] [Abstract][Full Text] [Related]
3. Analyze and compare the predictors of ipsilateral central lymph node metastasis in papillary thyroid carcinoma with cT1a and cT1b stage.
Zhou B; Wei L; Qin J
Asian J Surg; 2021 Nov; 44(11):1357-1362. PubMed ID: 33715963
[TBL] [Abstract][Full Text] [Related]
4. Total tumor diameter is a better indicator of multifocal papillary thyroid microcarcinoma: A propensity score matching analysis.
Jiang KC; Lin B; Zhang Y; Zhao LQ; Luo DC
Front Endocrinol (Lausanne); 2022; 13():974755. PubMed ID: 36004348
[TBL] [Abstract][Full Text] [Related]
5. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.
Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Risk Factors Associated With Central Lymph Node Metastasis in Papillary Thyroid Carcinoma With cT1N0 Stage.
Zhao YZ; He NA; Ye XJ; Jin F; Li MX; Jiang X
Front Endocrinol (Lausanne); 2022; 13():880911. PubMed ID: 35733781
[TBL] [Abstract][Full Text] [Related]
7. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
8. Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma.
Zhao Q; Ming J; Liu C; Shi L; Xu X; Nie X; Huang T
Ann Surg Oncol; 2013 Mar; 20(3):746-52. PubMed ID: 22972508
[TBL] [Abstract][Full Text] [Related]
9. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer.
Tam AA; Özdemir D; Çuhacı N; Başer H; Aydın C; Yazgan AK; Ersoy R; Çakır B
Endocrine; 2016 Sep; 53(3):774-83. PubMed ID: 27090526
[TBL] [Abstract][Full Text] [Related]
10. Can ratio of the biggest tumor diameter to total tumor diameter be a new parameter in the differential diagnosis of agressive and favorable multifocal papillary thyroid microcarcinoma?
Tam AA; Özdemir D; Çuhacı N; Başer H; Dirikoç A; Aydın C; Yazgan AK; Ersoy R; Çakır B
Oral Oncol; 2017 Feb; 65():1-7. PubMed ID: 28109462
[TBL] [Abstract][Full Text] [Related]
11. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.
Luo Y; Zhao Y; Chen K; Shen J; Shi J; Lu S; Lei J; Li Z; Luo D
J Endocrinol Invest; 2019 Feb; 42(2):227-236. PubMed ID: 29876836
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma (CN0): a study of 273 resections.
Li M; Zhu XY; Lv J; Lu K; Shen MP; Xu ZL; Wu ZS
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3801-3807. PubMed ID: 28975988
[TBL] [Abstract][Full Text] [Related]
13. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
14. Predicting factors of central lymph node metastases in patients with unilateral multifocal papillary thyroid microcarcinoma.
Wu X; Li B; Zheng C; He X
Gland Surg; 2020 Jun; 9(3):695-701. PubMed ID: 32775259
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients.
Zhang L; Wei WJ; Ji QH; Zhu YX; Wang ZY; Wang Y; Huang CP; Shen Q; Li DS; Wu Y
J Clin Endocrinol Metab; 2012 Apr; 97(4):1250-7. PubMed ID: 22319042
[TBL] [Abstract][Full Text] [Related]
16. Total tumour diameter is superior to unifocal diameter as a predictor of papillary thyroid microcarcinoma prognosis.
Liu C; Wang S; Zeng W; Guo Y; Liu Z; Huang T
Sci Rep; 2017 May; 7(1):1846. PubMed ID: 28500312
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study.
Gui CY; Qiu SL; Peng ZH; Wang M
J Endocrinol Invest; 2018 Apr; 41(4):403-409. PubMed ID: 28884301
[TBL] [Abstract][Full Text] [Related]
18. The value of total tumor diameter in unilateral multifocal papillary thyroid carcinoma: a propensity score matching analysis.
Wu ZJ; Xia BY; Chen ZW; Gong H; Abuduwaili M; Xing ZC; Su AP
Front Endocrinol (Lausanne); 2023; 14():1217613. PubMed ID: 37745721
[TBL] [Abstract][Full Text] [Related]
19. Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?
Chang YW; Kim HS; Kim HY; Lee JB; Bae JW; Son GS
Asian J Surg; 2016 Oct; 39(4):197-201. PubMed ID: 25913730
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
